InnoSIGN
PrivateLast Round
Series A
Extension
Jul 26, 2022
Total Funding Raised
$10.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
InnoSIGN is a biotechnology company that provides mRNA-based pathway activity profiling technology to support diagnostics and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InnoSIGN Comparables
Compare InnoSIGN with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AnyGenes | 77% | |
| DarwinHealth | 77% | |
| Metamorphosis Tx B.V. | 72% |
InnoSIGN Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 26, 2022 | ||||
| Series A | Mar 22, 2022 |
Key People
Founding team and executive leadership
InnoSIGN Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brabantse Ontwikkelings Maatschappij | Series A |
| Brabantse Ontwikkelings Maatschappij | Series A |
| Tech Coast Angels | Series A Extension |
| Thuja Capital | Series A |
| Casdin Capital | Series A |
| TCA Venture Group | Series A |
| Life Science Angels | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 1144% MoM.
- Mar 22, 2022
$9.2M round led by Casdin Capital and Thuja Capital.
InnoSIGN Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about InnoSIGN's valuation, stock price, and market status.
Is InnoSIGN a public or private company?
InnoSIGN is a private company.
What is the current stock price of InnoSIGN?
InnoSIGN is a private company with no public stock price. No recent secondary market data is available.
How much is InnoSIGN worth (valuation)?
Valuation information for InnoSIGN is not publicly available.
Can I buy InnoSIGN stock?
InnoSIGN shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was InnoSIGN's last funding round?
InnoSIGN's most recent funding round was Series A Extension on July 26, 2022.
Who are the main investors in InnoSIGN?
Key investors in InnoSIGN include Thuja Capital, Casdin Capital.
Will InnoSIGN IPO soon?
No public IPO plans have been announced for InnoSIGN.
How can I track InnoSIGN secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor InnoSIGN's secondary market activity and sign up for updates.